Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Treating Neurodegenerative Diseases with Nicotine Receptor Ligands

Technology #99089

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Collections
Image Gallery
Neurodegenerative DiseasesNicotine AgonistNicotine Receptor
Categories
Researchers
Simon Efange, PhD
Managed By
Raj Udupa
Technology Licensing Officer 612-624-3966
Patent Protection
US Patent 6,846,817

Nicotine Receptor Ligands Show Neuroprotective Effects

Nicotine receptor ligands have the potential to provide a treatment option for neurodegenerative diseases like Alzheimer’s and Parkinson’s disease. The nicotine-like compounds in these agonists have shown neuroprotective effects that may help to slow the progression of these neurodegenerative diseases and have some memory enhancing effects. Preliminary testing in animals has shown indications of enhanced memory as well as alleviation of chronic pain. These nicotine receptor ligands have shown to be more efficacious than morphine in pain suppression and without the detrimental side effects often seen in chronic pain treatments.

MN-IP Try and Buy
Try
  • This research method is immediately available for a nonexclusive license.
Buy
  • A nonexclusive license for a $10,000 fee.
  • Royalty rate of 2% or 1% for MN-based companies.
  • Royalty free for the first $1MM in Sales
  • No patent expenses due.

** View the Term Sheet **
** Contact Raj Udupa for more information. **

Nicotinic Agonists

A method to improve the efficacy of a new class of nicotine agonists that focus on regulating nicotine receptor function has been discovered. These nicotinic agonists are responsible for stimulating neurotransmitters that aid in the modulation of neuroendocrine function, respiration, mood, motor control and function, memory, and cognition. This more potent class of compounds shows promise in new medications for the treatment of neurodegenerative diseases like Alzheimer’s and Parkinson’s disease as well as potential to help manage chronic pain.

BENEFITS OF NICOTINE RECEPTOR LIGANDS:

  • Potential treatment option for neurodegenerative diseases - neuroprotective effects that may arrest progression of disease
  • Some memory enhancing effects
  • Management of chronic pain-more potent and efficacious than morphine in pain suppression
  • No detrimental side effects